S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 RetrophinHomology MedicinesVanda PharmaceuticalsCara TherapeuticsKiniksa Pharmaceuticals
SymbolNASDAQ:RTRXNASDAQ:FIXXNASDAQ:VNDANASDAQ:CARANASDAQ:KNSA
Price Information
Current Price$11.13$13.80$12.94$18.86$5.95
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$29.71$33.00$28.67$26.93$31.33
% Upside from Price Target166.97% upside139.13% upside121.54% upside42.78% upside426.61% upside
Trade Information
Market Cap$475.50 million$622.56 million$689.37 million$745.32 million$364.24 million
Beta0.80.090.322.22-1.35
Average Volume487,615237,491781,351742,327113,410
Sales & Book Value
Annual Revenue$164.25 million$3.68 million$193.12 million$13.47 millionN/A
Price / Sales2.91164.873.5756.05N/A
CashflowN/AN/A$0.55 per shareN/AN/A
Price / CashN/AN/A23.41N/AN/A
Book Value$7.72 per share$5.19 per share$5.25 per share$3.38 per share$5.64 per share
Price / Book1.442.662.465.58N/A
Profitability
Net Income$-102,680,000.00$-57,220,000.00$25.20 million$-74,010,000.00$-103,230,000.00
EPS($2.54)($2.00)$0.48($2.06)($3.49)
Trailing P/E RatioN/AN/A26.96N/AN/A
Forward P/E RatioN/AN/A15.78N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-83.94%-3,232.67%13.61%-420.97%N/A
Return on Equity (ROE)-47.21%-38.74%10.23%-68.36%-57.63%
Return on Assets (ROA)-20.67%-30.47%8.32%-46.96%-51.38%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.72%N/AN/A0.04%N/A
Current Ratio5.05%19.29%5.05%3.11%9.82%
Quick Ratio4.99%19.29%5.03%3.11%9.82%
Ownership Information
Institutional Ownership PercentageN/A68.09%N/A64.92%30.22%
Insider Ownership Percentage4.32%33.40%8.20%5.80%70.63%
Miscellaneous
Employees21412427055111
Shares Outstanding42.95 million43.97 million53.27 million40.03 million54.86 million
Next Earnings Date11/7/2019 (Estimated)11/12/2019 (Estimated)11/6/2019 (Estimated)11/5/2019 (Estimated)11/7/2019 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable
 RetrophinHomology MedicinesVanda PharmaceuticalsCara TherapeuticsKiniksa Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel